10. Januar 2020
Global Data Hub – 15 von 17 Insights
We have a fresh batch of content on our Taylor Wessing Global Data Hub site which provides you with insight and guidance on data privacy issues.
We look at the impact of the GDPR on life sciences data and at particular issues with using personal data in clinical trials, connected devices and life sciences AI.
Debbie Heywood takes a high level look at aspects of the GDPR which are particularly relevant to private sector life sciences businesses.
Jo Joyce discusses finding the balance between better data and best practice for data privacy in clinical trials and medical device testing.
Mary Rendle considers the challenges of finding the right lawful basis to process personal data for clinical trials.
Vin Bange and Lucie Audibert look at some of the GDPR compliance stress points in connected medical devices.
Jean-David Behlow looks at the growth of AI, machine learning and data analytics in the UK healthcare sector and at key data protection compliance issues.
Thanos Rammos looks at the approach of regulators, with a focus on Germany, to the use of personal data in life sciences and healthcare.
Helen Farr looks at the data protection implications of the EU Whistleblowing Directive and whistleblower hotlines more generally.
11. Juli 2022
von Helen Farr
Anna Taylor and Jo Joyce look at the data sharing requirements for the proposed pensions dashboard and resulting data protection considerations.
17. Mai 2022
von Jo Joyce
15. März 2022
von mehreren Autoren
14. Februar 2022
von mehreren Autoren
8. November 2021
von Debbie Heywood
9. August 2021
von Debbie Heywood
9. Oktober 2020
von mehreren Autoren
11. Februar 2019
von Debbie Heywood
6. März 2020
von mehreren Autoren
von Debbie Heywood